Marije K. Bomers

ORCID: 0000-0003-0399-6926
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Clostridium difficile and Clostridium perfringens research
  • Animal Virus Infections Studies
  • SARS-CoV-2 detection and testing
  • Neutropenia and Cancer Infections
  • Hepatitis C virus research
  • Sepsis Diagnosis and Treatment
  • Diabetes and associated disorders
  • Bacterial Identification and Susceptibility Testing
  • Hepatitis B Virus Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Advanced Chemical Sensor Technologies
  • Antibiotic Resistance in Bacteria
  • Olfactory and Sensory Function Studies
  • HIV Research and Treatment
  • Respiratory viral infections research
  • HIV, Drug Use, Sexual Risk
  • T-cell and B-cell Immunology
  • Liver Disease Diagnosis and Treatment
  • Microscopic Colitis
  • HIV-related health complications and treatments

Amsterdam University Medical Centers
2019-2024

Vrije Universiteit Amsterdam
2015-2024

University of Amsterdam
2020-2024

Stichting HIV Monitoring
2023

Public Health Service of Amsterdam
2023

Amsterdam UMC Location Vrije Universiteit Amsterdam
2010-2022

Institute of Infection and Immunity
2021-2022

Inserm
2021

Aidsfonds
2021

Corvid Technologies (United States)
2020

Mads Delbo Larsen Erik L. de Graaf Myrthe E. Sonneveld H. Rosina Plomp Jan Nouta and 94 more Willianne Hoepel Hung‐Jen Chen Federica Linty Remco Visser Maximilian Brinkhaus Tonći Šuštić Steven W. de Taeye Arthur E. H. Bentlage S Toivonen Carolien A. M. Koeleman Susanna Sainio Neeltje A. Kootstra Philip J. M. Brouwer Chiara E. Geyer Ninotska I. L. Derksen Gertjan Wolbink Menno P.J. de Winther Rogier W. Sanders Marit J. van Gils Sanne de Bruin Alexander P. J. Vlaar Theo Rispens Jeroen den Dunnen Hans L. Zaaijer Manfred Wuhrer C. Ellen van der Schoot Gestur Vidarsson Michiel A. van Agtmael Anne Geke Algera Frank van Baarle Diane Bax Diederik van de Beek Martijn Beudel Harm Jan Bogaard Peter I. Bonta Marije K. Bomers Lieuwe D. J. Bos Michela Botta Godelieve de Bree Matthijs C. Brouwer Justin de Brabander Sanne de Bruin Marianna Bugiani Esther Bulle Osoul Chouchane Alex Cloherty Paul Elbers Lucas M. Fleuren Suzanne E. Geerlings Bart F. Geerts Teunis B. H. Geijtenbeek Armand R. J. Girbes Abraham Goorhuis Martin P. Grobusch Florianne Hafkamp Laura A. Hagens Jörg Hamann Vanessa Harris Robert Hemke Sabine Hermans Leo Heunks Markus W. Hollmann Janneke Horn Joppe W. Hovius Menno D. de Jong Rutger Koning Niels van Mourik Diederik van de Beek Esther J. Nossent Frederique Paulus Edgar J.G. Peters Tom van der Poll Bennedikt Preckel Jan M. Prins Jorinde Raasveld Tom Rijnders Michiel Schinkel Marcus J. Schultz Alex Schuurmans Kim Sigaloff Marry R. Smit Cornelis Stijnis Willemke Stilma Charlotte E. Teunissen Patrick Thoral Anissa M. Tsonas Marc van der Valk Denise P. Veelo Alexander P. J. Vlaar Heder de Vries Michèle van Vugt W. Joost Wiersinga Dorien Wouters A. H. Zwinderman

Immunoglobulin G (IgG) antibodies are crucial for protection against invading pathogens. A highly conserved N-linked glycan within the IgG-Fc tail, which is essential IgG function, shows variable composition in humans. Afucosylated variants already used anticancer therapeutic their increased activity through Fc receptors (FcγRIIIa). Here, we report that afucosylated (approximately 6% of total humans) specifically formed enveloped viruses but generally not other antigens. This mediates...

10.1126/science.abc8378 article EN cc-by Science 2020-12-23
Sanne de Bruin Lieuwe D. J. Bos Marian A. van Roon Anita M. Tuip‐de Boer Alex R. Schuurman and 92 more Marleen J.A. Koel-Simmelinck Harm Jan Bogaard Pieter R. Tuinman Michiel A. van Agtmael Jörg Hamann Charlotte E. Teunissen W. Joost Wiersinga Aeilko H. Zwinderman Matthijs C. Brouwer Diederik van de Beek Alexander P. J. Vlaar Michiel A. van Agtmael Anne Geke Algera Brent Appelman Frank van Baarle Diane Bax Martijn Beudel Harm Jan Bogaard Marije K. Bomers Peter I. Bonta Lieuwe D. J. Bos Michela Botta Justin de Brabander Godelieve de Bree Sanne de Bruin David T.P. Buis Marianna Bugiani Esther Bulle Osoul Chouchane Alex Cloherty David T.P. Buis Maurits C. F. J. de Rotte Mirjam Dijkstra Dave A. Dongelmans Romein W. G. Dujardin Paul Elbers Lucas M. Fleuren Suzanne E. Geerlings Teunis B. H. Geijtenbeek Armand R. J. Girbes Abraham Goorhuis Martin P. Grobusch Florianne Hafkamp Laura A. Hagens Jörg Hamann Vanessa Harris Robert Hemke Sabine Hermans Leo Heunks Markus W. Hollmann Janneke Horn Joppe W. Hovius Menno D. de Jong Rutger Koning Endry H. T. Lim Niels van Mourik Jeannine F. Nellen Esther J. Nossent Frederique Paulus Edgar Peters Dan Piña‐Fuentes Tom van der Poll Bennedikt Preckel Jan M. Prins Jorinde Raasveld Tom D. Y. Reijnders Michiel Schinkel Femke A. P. Schrauwen Marcus J. Schultz Alex Schuurmans Jaap Schuurmans Kim Sigaloff Marleen A. Slim Patrick Smeele Marry R. Smit Cornelis Stijnis Willemke Stilma Charlotte E. Teunissen Patrick Thoral Anissa M. Tsonas Pieter R. Tuinman Marc van der Valk Denise P. Veelo Carolien Volleman Heder de Vries Lonneke A. van Vught Michèle van Vugt Dorien Wouters Aeilko H. Zwinderman Matthijs C. Brouwer W. Joost Wiersinga Alexander P. J. Vlaar

BackgroundMortality rates are high among hospitalized patients with COVID-19, especially in those intubated on the ICU. Insight pathways associated unfavourable outcome may lead to new treatment strategies.MethodsWe performed a prospective cohort study of COVID-19 admitted general ward or ICU who underwent serial blood sampling. To provide insight involved disease progression, associations were estimated between risk and measurements 64 biomarkers potential important infection (inflammation,...

10.1016/j.ebiom.2021.103378 article EN cc-by EBioMedicine 2021-05-01

Large-scale vaccination campaigns have prevented countless hospitalizations and deaths due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from immunity challenges effectiveness current vaccines. Given this continuing evolution, an important question is when how update vaccines antigenically match circulating variants, similarly seasonal influenza viruses where antigenic drift necessitates periodic vaccine updates. Here, we studied by assessing neutralizing activity...

10.1016/j.immuni.2022.07.018 article EN cc-by Immunity 2022-08-05

<b>Objective</b> To investigate whether a dog’s superior olfactory sensitivity can be used to detect <i>Clostridium difficile</i> in stool samples and hospital patients. <b>Design</b> Proof of principle study, using case-control design. <b>Setting</b> Two large Dutch teaching hospitals. <b>Participants</b> A 2 year old beagle trained identify the smell <i>C tested on 300 patients (30 with infection 270 controls). <b>Intervention</b> The dog was guided along wards by its trainer, who blinded...

10.1136/bmj.e7396 article EN cc-by-nc BMJ 2012-12-13

Abstract Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infections often cause only mild disease that may evoke relatively low Ab titers compared with patients admitted to hospitals. Generally, total bridging assays combine good sensitivity high specificity. Therefore, we developed sensitive for detection of SARS-CoV-2 Abs the receptor-binding domain (RBD) and nucleocapsid protein in addition conventional isotype-specific assays. kinetics was assessed PCR-confirmed, hospitalized...

10.4049/jimmunol.2000767 article EN The Journal of Immunology 2020-10-30

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not protect future novel coronavirus outbreaks, emphasizing the need for more broadly protective vaccines. To inform development of a pan-coronavirus vaccine, we investigated presence specificity cross-reactive antibodies spike (S) proteins human coronaviruses (hCoV) after infection vaccination. We found an 11- to 123-fold increase in binding SARS-CoV MERS-CoV as well 2- 4-fold difference seasonal hCoVs...

10.7554/elife.70330 article EN cc-by eLife 2021-11-16

Summary Large-scale vaccination campaigns have prevented countless hospitalizations and deaths due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from immunity challenges effectiveness current vaccines. Given this continuing evolution, an important question is when how update vaccines antigenically match circulating variants, similar seasonal influenza viruses where antigenic drift necessitates periodic vaccine updates. Here, we studied by assessing neutralizing...

10.1101/2022.01.03.21268582 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2022-01-03

Rationale: Bacterial lung microbiota are correlated with inflammation and acute respiratory distress syndrome (ARDS) altered in severe coronavirus disease (COVID-19). However, the association between (including fungi) resolution of ARDS COVID-19 remains unclear. We hypothesized that increased bacterial fungal burdens related to nonresolving mortality COVID-19. Objectives: To determine relation clinical outcomes COVID-19–related ARDS. Methods: This observational cohort study enrolled...

10.1164/rccm.202202-0274oc article EN cc-by-nc-nd American Journal of Respiratory and Critical Care Medicine 2022-05-26

Abstract SARS-CoV-2 infections worldwide led to a surge in cases of Long COVID, post-infectious syndrome. It has been hypothesized that autoantibodies play crucial role the development COVID and other syndromes, such as fibromyalgia myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In this study, we tested hypothesis by passively transferring total IgG from patients mice. Using Glial Fibrillary Acidic Protein (GFAP) type-I interferon expression, stratified into three subgroups,...

10.1101/2024.05.30.596590 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2024-05-31

Abstract Background Health-related quality of life (HRQoL) data post–COVID-19 in patients with medical conditions associated severe disease are lacking. Here, we assess the longitudinal impact COVID-19 on HRQoL and employment status individuals at high risk. Methods This multicenter prospective cohort study included risk for who were hospitalized or not-hospitalized SARS-CoV-2 infection (September 2021–February 2024). Questionnaires about collected 3, 6, 12 months retrospectively recalled...

10.1093/ofid/ofaf055 article EN cc-by Open Forum Infectious Diseases 2025-01-27
Elske Hoornenborg Liza Coyer Anders Boyd Roel Achterbergh Maarten Franciscus Schim van der Loeff and 95 more Sylvia M. Bruisten Henry J.C. de Vries Jelle Koopsen Thijs van de Laar Maria Prins Jan van Bergen Godelieve J. de Bree P. Brokx F. Deug M. Heidenrijk Maria Prins Peter Reiss Marc van der Valk Jan van Bergen Godelieve J. de Bree P. Brokx Udi Davidovich Suzanne E. Geerlings Elske Hoornenborg A. Oomen Ard van Sighem Wim Zuilhof M.L. Groot Bruinderink Roel Achterbergh Michiel A. van Agtmael Jintanat Ananworanich Diederik van de Beek G.E.L. van den Berk Daniela Bezemer A. van Bijnen W Blok S Bogers Marije K. Bomers Charles A. Boucher W. Brokking David M. Burger Kees Brinkman N. Brinkman Marijn de Bruin Sylvia M. Bruisten Liza Coyer Reinout van Crevel Ceranza G. Daans L. Dellemann Maartje Dijkstra Y. T. van Duijnhoven Arne van Eeden L. Elsenburg Mark A. M. van den Elshout Carmen Ester E. Ersan P. E. V. Felipa P. H. J. Frissen Teunis B. H. Geijtenbeek Mieke H. Godfried J. van Gool Abraham Goorhuis Marco R. de Groot Catherine Hankins A. Heijnen M Hillebregt A.A. Hogewoning M. Hommenga Joppe W. Hovius Y. J. H. Janssen K. De Jong Vita W. Jongen Neeltje A. Kootstra Richard A. Koup Frank P. Kroon Thijs van de Laar Fanny N. Lauw M.M. van Leeuwen Kamilla D. Lettinga Ineke Linde Dominique Loomans J. T. van der Meer T. Mouhebati Barbara J.M. Mulder Jan Mulder F.J.B. Nellen A. Nijsters H. Nobel Paul M. Oostvogel Eline Op de Coul Edgar J.G. Peters Inga Peters T. van der Poll Oliver Ratmann Casper Rokx Martijn S. van Rooijen Maarten F. Schim van der Loeff W.E.M. Schoute Gerard J.B. Sonder Jan A. Veenstra

10.1016/j.jhep.2019.11.022 article EN publisher-specific-oa Journal of Hepatology 2019-12-18
Colette Smit Anders Boyd Bart Rijnders Thijs van de Laar Eliane M.S. Leyten and 95 more Wouter F.W. Bierman Kees Brinkman Mark Claassen Jan den Hollander Anne Boerekamps Astrid M. Newsum Janke Schinkel Maria Prins Joop E. Arends Eline Op de Coul Marc van der Valk Peter Reiss Marc van der Valk Suzanne E. Geerlings Abraham Goorhuis Joppe W. Hovius B. Lempkes F.J.B. Nellen T. van der Poll Jan M. Prins Michèle van Vugt W. Joost Wiersinga F.W.M.N. Wit Marlies van Duinen J. van Eden A. Hazenberg A M H van Hes F J J Pijnappel S Smalhout Annouschka M. Weijsenfeld Suzanne Jurriaans Nicole Back Hans L. Zaaijer B. Berkhout Marion Cornelissen C. Schinkel Katja C. Wolthers Edgar J.G. Peters Michiel A. van Agtmael Reshma Autar Marije K. Bomers Kim Sigaloff M. Heitmuller Liedewij Laan C. Wim Ang Robin van Houdt Marcel Jonges Maarten van den Berge Arjan Stegeman S. Baas L. Hage de Looff A. G. M. Buiting Anne Q. Reuwer Jacobien Veenemans Bas Wintermans M.J.H. Pronk Heidi S. M. Ammerlaan D. N. J. van den Bersselaar E. S. de Munnik Birgit Deiman A R Jansz Volkher Scharnhorst Jeroen H. T. Tjhie M.C.A. Wegdam Arne van Eeden Jeannine F. Nellen W. Brokking L. Elsenburg H. Nobel C. Schinkel M.E.E. van Kasteren Marvin A. H. Berrevoets Annemarie E. Brouwer Andrew L. Adams R. van Erve B.A.F.M. de Kruijf-van de Wiel S. Keelan-Phaf B. van de Ven A. G. M. Buiting J.L. Murck T.E.M.S. de Vries-Sluijs Hannelore I. Bax Eric C. M. Van Gorp N. C. de Jong-Peltenburg Martim Melo Els van Nood Jan Nouwen Bart Rijnders Casper Rokx Carolina A. M. Schurink Lennert Slobbe Annelies Verbon N. Bassant J. E. A. van Beek M. Vriesde

10.1016/s2352-3018(20)30301-5 article EN The Lancet HIV 2020-12-22

<h3>Importance</h3> It is unclear when, where, and by whom health care workers (HCWs) working in hospitals are infected with SARS-CoV-2. <h3>Objective</h3> To determine how often what manner nosocomial SARS-CoV-2 infection occurs HCW groups varying exposure to patients COVID-19. <h3>Design, Setting, Participants</h3> This cohort study comprised 4 weekly measurements of SARS-CoV-2–specific antibodies collection questionnaires from March 23 June 25, 2020, combined phylogenetic epidemiologic...

10.1001/jamanetworkopen.2021.18554 article EN cc-by-nc-nd JAMA Network Open 2021-07-28

Afucosylated IgG1 responses have only been found against membrane-embedded epitopes, including anti-S in SARS-CoV-2 infections. These responses, intrinsically protective through enhanced FcγRIIIa binding, can also trigger exacerbated pro-inflammatory severe COVID-19. We investigated if the BNT162b2 mRNA induced afucosylated IgG responses.Blood from vaccinees during first vaccination wave was collected. Liquid chromatography-Mass spectrometry (LC-MS) used to study Fc glycoprofiles....

10.1016/j.ebiom.2022.104408 article EN cc-by-nc-nd EBioMedicine 2022-12-16
Lihui Guo Brent Appelman Kirsten Mooij‐Kalverda Riekelt H. Houtkooper Michel van Weeghel and 91 more Frédéric M. Vaz Annemiek Dijkhuis Tamara Dekker Barbara Smids JanWillem Duitman Marianna Bugiani Paul Brinkman Jonne J. Sikkens H.A. Ayesha Lavell Rob C. I. Wüst Michèle van Vugt René Lutter Michiel A. van Agtmael Anne Geke Algera Brent Appelman Frank E.H.P. van Baarle Martijn Beudel Harm Jan Bogaard Marije K. Bomers Peter I. Bonta Lieuwe D. J. Bos Michela Botta Justin de Brabander Godelieve J. de Bree Sanne de Bruin Marianna Bugiani Esther Bulle Osoul Chouchane Alex Cloherty Dennis R. Buis Maurits C. F. J. de Rotte Maartje Dijkstra Dave A. Dongelmans Romein W. G. Dujardin Paul Elbers Lucas M. Fleuren Suzanne E. Geerlings Teunis B. H. Geijtenbeek Armand R. J. Girbes Abraham Goorhuis Martin P. Grobusch Laura A. Hagens Jörg Hamann Vanessa Harris Robert Hemke Sabine Hermans Leo Heunks Markus W. Hollmann Janneke Horn Joppe W. Hovius Menno D. de Jong R. Koing Endry H. T. Lim Niels van Mourik Diederik van de Beek Esther J. Nossent Frederique Paulus Edgar J.G. Peters Dan Piña‐Fuentes Tom van der Poll Benedikt Preckel Jan M. Prins Jorinde Raasveld Tom D. Y. Reijnders Michiel Schinkel Femke A. P. Schrauwen Marcus J. Schultz Alex R. Schuurman Jaap Schuurmans Kim Sigaloff Marleen A. Slim Patrick Smeele Marry R. Smit Cornelis Stijnis Willemke Stilma Charlotte E. Teunissen Patrick Thoral Anissa M. Tsonas Pieter R. Tuinman Marc van der Valk Denise P. Veelo Carolien Volleman Heder de Vries Lonneke A. van Vught Michèle van Vugt Dorien Wouters Aeilko H. Zwinderman Matthijs C. Brouwer W. Joost Wiersinga Alexander P. J. Vlaar Diederik van de Beek

BackgroundPost-acute sequela of SARS-CoV-2 infection (PASC) encompass fatigue, post-exertional malaise and cognitive problems. The abundant expression the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase-2 (IDO2) in fatal/severe COVID-19, led us to determine, an exploratory observational study, whether IDO2 is expressed active PASC, may correlate with pathophysiology.MethodsPlasma or serum, peripheral blood mononuclear cells (PBMC) were obtained from well-characterized PASC...

10.1016/j.ebiom.2023.104729 article EN cc-by EBioMedicine 2023-07-26

Background Chest CT displays chest pathology better than X-ray (CXR). We evaluated the effects on health outcomes of replacing CXR by ultra-low-dose chest-CT (ULDCT) in diagnostic work-up patients suspected non-traumatic pulmonary disease at emergency department. Methods Pragmatic, multicentre, non-inferiority randomised clinical trial Between 31 January 2017 and May 2018, every month, participating centres were randomly allocated to using ULDCT or CXR. Primary outcome was functional 28...

10.1136/thoraxjnl-2021-218337 article EN cc-by-nc Thorax 2022-06-10
Erik H.A. Michels Brent Appelman Justin de Brabander Rombout B. E. van Amstel Osoul Chouchane and 92 more Christine C. A. van Linge Alex R. Schuurman Tom D. Y. Reijnders Titia A.L. Sulzer Augustijn M. Klarenbeek Renée A. Douma Lieuwe D. J. Bos W. Joost Wiersinga Hessel Peters‐Sengers Tom van der Poll Michiel A. van Agtmael Anne Geke Algera Brent Appelman Floor van Baarle Martijn Beudel Harm Jan Bogaard Marije K. Bomers Peter I. Bonta Lieuwe D. J. Bos Michela Botta Justin de Brabander Godelieve de Bree Sanne de Bruin Marianna Bugiani Esther Bulle David T.P. Buis Osoul Chouchane Alex Cloherty Mirjam Dijkstra Dave A. Dongelmans Romein W. G. Dujardin Paul Elbers Lucas M. Fleuren Suzanne E. Geerlings Teunis B. H. Geijtenbeek Armand R. J. Girbes Abraham Goorhuis Martin P. Grobusch Laura A. Hagens Jörg Hamann Vanessa Harris Robert Hemke Sabine Hermans Leo Heunks Markus W. Hollmann Janneke Horn Joppe W. Hovius Hanna K. de Jong Menno D. de Jong Rutger Koning Bregje Lemkes Endry H. T. Lim Niels van Mourik Diederik van de Beek Esther J. Nossent Sabine Olie Frederique Paulus Edgar Peters Dan Piña‐Fuentes Tom van der Poll Bennedikt Preckel Jan M. Prins Jorinde Raasveld Tom D. Y. Reijnders Maurits C. F. J. de Rotte Michiel Schinkel Marcus J. Schultz Femke A. P. Schrauwen Alex R. Schuurman Jaap Schuurmans Kim Sigaloff Marleen A. Slim Patrick Smeele Marry R. Smit Cornelis Stijnis Willemke Stilma Charlotte E. Teunissen Patrick Thoral Anissa M. Tsonas Pieter R. Tuinman Marc van der Valk Denise P. Veelo Carolien Volleman Heder de Vries Lonneke A. van Vught Michèle van Vugt Dorien Wouters A. H. Zwinderman Matthijs C. Brouwer W. Joost Wiersinga Alexander P. J. Vlaar Diederik van de Beek

Background Coronavirus disease 2019 (COVID-19)-induced mortality occurs predominantly in older patients. Several immunomodulating therapies seem less beneficial these The biological substrate behind observations is unknown. aim of this study was to obtain insight into the association between ageing, host response and patients with COVID-19. Methods We determined 43 biomarkers reflective alterations four pathophysiological domains: endothelial cell coagulation activation, inflammation organ...

10.1183/13993003.00011-2023 article EN cc-by-nc European Respiratory Journal 2023-04-20

IgG antibodies are important mediators of vaccine-induced immunity through complement- and Fc receptor-dependent effector functions. Both influenced by the composition conserved N-linked glycan located in domain. Here, we compared anti-Spike (S) IgG1 glycosylation profiles response to mRNA, adenoviral, protein-based COVID-19 vaccines mass spectrometry (MS). All induced a transient increase antigen-specific galactosylation sialylation. An initial, afucosylated was membrane-encoding S protein...

10.1016/j.isci.2023.107619 article EN cc-by-nc-nd iScience 2023-08-14

Inflammatory bowel disease (IBD), including Crohn's (CD) and ulcerative colitis (UC), remains challenging to diagnose. Diagnostic work-up carries a high burden, especially in paediatric patients, due invasive endoscopic procedures. IBD is associated with alterations intestinal microbiota composition. Faecal volatile organic compounds (VOCs) reflect gut The aim of this study was assess the diagnostic accuracy faecal VOC profiling as non-invasive biomarker for IBD.In performed two tertiary...

10.1088/1752-7163/aa6f1d article EN Journal of Breath Research 2017-04-25
Coming Soon ...